Edgardo Adorno-Fontanez, MD
Pulmonary Disease · San Juan, PRNPI 1063615508
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (58.3%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Intuitive Surgical at 58.7% of the total.
Across 22 payments — averaging $194.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$3K
- Olympus Corporation Of The Americas$1K
- Johnson & Johnson$114
- Medtronic$72
- Gilead$63
- E.r. Squibb & Sons, L.L.C.$60
- plus $49 from 1 others
What the payments were for
- Travel & lodging$1,19428%
- Food & beverage$59014%
- Education$2,50058%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 2 | $2,517 |
| Olympus Corporation Of The Americas | 12 | $1,409 |
| Johnson & Johnson | 2 | $114 |
| Medtronic | 1 | $72 |
| Gilead | 2 | $63 |
| E.r. Squibb & Sons, L.L.C. | 1 | $60 |
| Olympus Latin America, Inc. | 2 | $49 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$2,500
- Olympus EBUS Bronchoscopes$1,194
- EVIS EXERA$652
How this compares
$4,285 in reported general payments places this provider in the 65th percentile of 138 pulmonary disease providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OfevNintedanib Esylate | 14 | $181,224 |
| Spiriva RespimatTiotropium Bromide | 35 | $18,691 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 21 | $10,207 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 13 | $8,666 |
| Wixela InhubFluticasone Propion/Salmeterol | 36 | $6,998 |
| Fluticasone Propionate HfaFluticasone Propionate | 14 | $3,794 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 12 | $3,070 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 38 | $1,877 |
| Fluticasone Propionate | 19 | $236 |
| Montelukast Sodium | 28 | $188 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in San Juan
- Joel Nieves ScharonSan Juan$43K
- Luis Gerena MontanoSan Juan$15K
- Rafael Franjul JuliaoSan Juan$15K
- Roberto Martinez QuintanaSan Juan$12K
- Sandra Rosario LebronSan Juan$11K
- Juan Malpica-SantiagoSan Juan$11K
- Daphne Delgado PerezSan Juan$10K
- Maximo Blondet PassalacquaSan Juan$8K
- Pedro Monroig QuilesSan Juan$6K
- Marieliz Alvarado DavilaSan Juan$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.